Many patients who come to our Lakewood Ranch clinic with neuropathy symptoms have already been through a spine workup. The MRI shows some disc changes, but the imaging findings do not fully explain what they are experiencing. The tingling persists. The burning at night continues. Something is being missed.
In a significant number of those cases, vitamin B12 deficiency is part of the picture. Sometimes it is the primary driver. Sometimes it is compounding structural nerve compression that was already present. Either way, it tends to go unidentified until someone specifically looks for it. If you are managing ongoing nerve symptoms and have not had a thorough evaluation, our neuropathy program is designed to look at both structural and nutritional contributors rather than treating them in isolation.
What B12 Does for Your Nervous System
Every nerve in your body is wrapped in a layer of protective insulation called the myelin sheath. Myelin allows nerve signals to travel quickly and accurately. Without adequate myelin, those signals slow down, misfire, or fail to reach their destination, which is what produces the sensory symptoms that define peripheral neuropathy: tingling, numbness, burning, and in more advanced cases, weakness.
Vitamin B12 is essential for producing and maintaining myelin. It is not optional. When B12 is insufficient, myelin production falters and the existing sheath begins to thin in a process called demyelination. Demyelination does not happen overnight. It develops gradually, which is why B12 deficiency neuropathy is often well established by the time a patient realizes something is wrong.
The pattern of B12-related nerve damage follows a specific distribution. The longest nerves in the body require the most myelin to maintain, so they are the first to show signs of deficiency. That is why B12 neuropathy almost always begins in the feet and lower legs before reaching the hands. This "length-dependent" pattern is one of the features that distinguishes B12-driven neuropathy from disc-related nerve compression, which tends to follow dermatomal lines tied to specific spinal levels.
The Symptoms That Point to B12 Deficiency
B12 deficiency neuropathy tends to produce a recognizable cluster of symptoms, though the presentation varies by how far the deficiency has progressed:
- Tingling or pins-and-needles in the feet and toes, often spreading upward toward the ankles and lower legs
- Numbness or reduced sensation in the soles of the feet
- Burning in the feet, frequently worse at night and during rest
- Balance problems or an unsteady gait, particularly in dim lighting where visual compensation is reduced
- Leg weakness in more progressed cases
- Cognitive fog or memory difficulty that does not resolve with adequate sleep
The nighttime worsening pattern is worth noting. Burning feet syndrome, where the feet become intensely uncomfortable at night, is one of the characteristic features of B12-related neuropathy and is covered in more depth in our post on burning feet at night. If this pattern describes what you are experiencing, B12 status is one of the first things worth evaluating.
B12 deficiency can also produce neurological symptoms beyond peripheral neuropathy, including subacute combined degeneration of the spinal cord in severe and prolonged cases. This involves the dorsal columns and corticospinal tracts and produces balance and coordination problems that go beyond what simple peripheral nerve damage would explain. This is a less common but more serious presentation that warrants prompt medical evaluation.
Who Is Most at Risk
B12 deficiency is not randomly distributed. There are identifiable groups with meaningfully elevated risk, and knowing whether you fall into one of them changes how urgently a B12 evaluation is warranted.
Older adults. Stomach acid is required to separate B12 from the food proteins it is bound to. Gastric acid production declines with age, and many people over 60 have subclinical B12 insufficiency for this reason alone. Even with a diet that contains adequate B12, the absorption mechanism becomes less efficient over time.
Metformin users. Metformin is one of the most prescribed medications in the world for managing type 2 diabetes. It also impairs B12 absorption through the gut by interfering with calcium-dependent uptake in the ileum. The clinical irony is significant: diabetes is itself a leading cause of peripheral neuropathy, and the medication commonly used to manage blood sugar can compound nerve damage by lowering B12. This combination is more common in our clinic than most patients realize, and it is worth raising with your prescribing physician if you are on long-term metformin.
Vegans and long-term vegetarians. B12 is found almost exclusively in animal-derived foods. Plant-based eaters without consistent supplementation or fortified food intake will eventually deplete their stores. Because the body can hold B12 reserves for several years, deficiency often develops gradually and without clear dietary warning signs. Patients sometimes have no idea their levels have dropped until symptoms emerge.
People with gastrointestinal conditions. Celiac disease, Crohn's disease, and other conditions affecting the small intestine impair absorption of B12 and other micronutrients. Patients who have had gastric bypass or sleeve gastrectomy surgery are also at elevated risk due to the structural changes in how food moves through the digestive tract and where absorption occurs.
Long-term acid suppressant users. Proton pump inhibitors (PPIs) and H2 blockers reduce stomach acid as intended. A secondary effect is reduced B12 absorption, because stomach acid is needed to free B12 from dietary proteins. Years of daily PPI use is a recognized risk factor for B12 insufficiency, particularly in older adults who may already have reduced acid production.
Why B12 Neuropathy Is Frequently Missed
The standard serum B12 test is a reasonable starting point but has significant limitations that lead to many cases being dismissed as "normal." Laboratory reference ranges vary widely, and a level that falls within the accepted range can still represent functional deficiency at the cellular level.
Two additional markers provide a clearer picture:
Methylmalonic acid (MMA). MMA is a metabolic byproduct that accumulates when B12 is functionally insufficient, even if serum B12 looks acceptable. Elevated MMA in the presence of a normal B12 is a recognized indicator of functional deficiency and a more sensitive marker for identifying nerve-relevant insufficiency.
Homocysteine. Elevated homocysteine occurs with B12 insufficiency as well as deficiency in B6 and folate. When a patient has neuropathy symptoms alongside elevated homocysteine, B12 status warrants closer examination even if the standard serum test appears normal.
Neither MMA nor homocysteine is typically included in a routine lab panel. If you have neuropathy symptoms and have been told your B12 "looks fine," it is reasonable to specifically ask your physician about these two markers. A patient with tingling feet, a serum B12 of 230 pg/mL, and elevated MMA is a very different clinical situation than the borderline-normal lab result alone suggests.
When B12 Deficiency and Spinal Issues Overlap
This is the situation we encounter most often at Spine and Wellness Center Lakewood Ranch. A patient has a documented disc herniation at L4-L5 with right-leg tingling. Structural care produces improvement but does not resolve the symptoms entirely. Then we identify B12 insufficiency and address it alongside the ongoing structural work. The remaining symptoms begin to respond.
The mechanism behind this overlap is straightforward. Disc compression reduces blood supply to the affected nerve root, limiting the nutrients and oxygen it receives. B12 deficiency simultaneously reduces the myelin that nerve depends on to function. When both are present, the nerve is under stress from two directions at once. Addressing only one side of that equation leaves the other unaddressed and limits how much improvement is possible.
This combined picture is part of why our approach to neuropathy involves evaluating the whole clinical picture rather than assuming the visible structural finding explains everything. Our posts on peripheral neuropathy causes and treatment and on our neuropathy recovery program go deeper into this multi-factor framework.
For a broader overview of the neuropathy conditions we work with and the range of presentations we see in the clinic, the neuropathy overview page covers the primary categories.
What a Proper Evaluation Looks Like
A first visit for neuropathy at our clinic includes a detailed intake covering medication history, dietary patterns, gastrointestinal conditions, and the timeline of how symptoms have developed. These details matter because a patient on long-term metformin who is also over 65 and has been vegetarian for a decade presents a very different risk profile than someone with similar symptoms and no apparent risk factors.
The physical exam characterizes the symptom distribution. Length-dependent neuropathy that affects both feet symmetrically and progresses upward over time looks different from a dermatomal presentation that follows a single nerve root from the spine. This distinction shapes what we investigate next and what we rule in or out structurally.
When the history and exam suggest B12 as a contributing factor, we coordinate with the patient's primary care physician to request appropriate laboratory work. We do not prescribe supplements in isolation or encourage patients to self-treat without understanding whether an absorptive problem is driving the deficiency. A low B12 from inadequate dietary intake requires a different approach than a low B12 from pernicious anemia or post-surgical malabsorption, and treating them identically is not appropriate.
For patients where the evaluation points to both structural and metabolic contributors, the plan addresses both. Structural care targets nerve compression and mobility. Nutritional repletion, coordinated with the patient's care team, addresses the myelin side of the equation. These are not competing approaches. They are complementary, and the evidence supports managing them together.
The Treatment Picture
B12 deficiency neuropathy, when identified before significant and irreversible nerve damage has occurred, can respond well to repletion. The timeline and degree of improvement depend on how long the deficiency went unaddressed and how much myelin loss has accumulated.
Early-stage cases with primarily sensory symptoms, tingling, reduced sensation, and mild burning, often see meaningful improvement over several months of proper repletion and monitoring. More advanced cases with significant sensory loss or established weakness take longer and may not fully reverse, but stabilization and partial recovery are realistic goals for many patients. In our experience, the earlier the deficiency is identified and corrected, the better the outcomes tend to be.
The form of B12 used for repletion matters in some cases. Methylcobalamin, the bioactive form of B12, is generally preferred for neurological applications because it does not require conversion in the body before it is usable. For patients with absorptive deficits, oral supplementation may not be sufficient regardless of dose, and sublingual or intramuscular routes may be more appropriate. These decisions are best made with a physician who has reviewed the full clinical picture.
For patients managing neuropathy in the Lakewood Ranch, Bradenton, or Sarasota area who want a thorough evaluation that includes both structural and nutritional contributors, our neuropathy program is structured around exactly that kind of complete assessment. If you have been told your B12 is fine but your symptoms continue, the next step is a more complete look at the picture.
